Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?

Madhuri M. Sopirala

Recent findings
Apart from immune dysregulation, severe resource limitations in healthcare settings have made COVID-19 units conducive to a variety of secondary infections. Long-term effect of excess antibiotic use in COVID-19 patients is yet to be studied. Very few studies have assessed secondary infections as the primary outcome measure making it difficult to know the true incidence. Mortality attributable to secondary infections in COVID-19 patients is also unclear.

Summary
Incidence of secondary infections in COVID-19 patients is likely higher than what is reported in the literature. Well designed studies are needed to understand the incidence and impact of secondary infections in this patient population. Many of these may be preventable especially now, as personal protective equipment and other healthcare resources are recovering. Infection prevention and control (IPC) and antimicrobial stewardship programmes (ASP) must reassess current situation to correct any breaches that could potentially cause more harm in these already vulnerable patients as we brace for a future surge with another pandemic wave.

Register in advance for this meeting:

https://zoom.us/meeting/register/tJIufu2trDsrGtPt0Uu1CIn9ATzUlNeN9d7V

After registering, you will receive a confirmation email containing information about joining the meeting.